She Dealt with the Anguish of Losing Her Dad to Esophageal Cancer …
And went on to win the Silver Medal in the [...]
Three New Immunotherapy Indications for Esophageal Cancer Patients
Since March 2021, the U.S. Food and Drug Administration has [...]
A Reason for Optimism
This is the 13th anniversary of my husband's death. It [...]
ECAN Experts cited in US News & World Report
"Esophageal Cancer: What to Know" is a new report from [...]
FDA Fast-Tracks Review of 3 New Immunotherapy Options for Esophageal Cancer Patients
The U.S. Food & Drug Administration has granted Priority Review [...]
New Treatment Option for Patients with HER2+ Gastroesophageal Junction Adenocarcinoma
The U.S. Food & Drug Administration has approved a new [...]
Latest US Stats Show More Esophageal Cancer Cases, Fewer Deaths
The latest statistics released by the American Cancer Society projects [...]
Hope is Important
These are challenging times. And we at ECAN are [...]
2020 Wins for Esophageal Cancer Patients
Despite the challenges of 2020, progress was achieved in the [...]
Groundbreaking Immunotherapy Studies in Esophageal Cancer show Significant Benefits
Findings of three studies important to Esophageal Cancer patients were [...]
ECAN Advocates Convince Congress to Include Esophageal Cancer in a Multi-Million Dollar Research Fund
For the second year in a row, thousands of ECAN [...]
FDA Approves First Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
The U.S. Food and Drug Administration has approved Keytruda (Pembrolizumab) [...]